Publications by authors named "Andras Seres"

Claim this Profile
I
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Ninety-Six-Week Results from the Randomized Phase 2/3 PHOTON Trial.
Diana V Do, Charles C Wykoff, Sobha Sivaprasad, David M Brown, David S Boyer, András Seres

Ophthalmology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of publication of the 48-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edema.
David M Brown, David S Boyer, Diana V Do, Charles C Wykoff, Taiji Sakamoto, András Seres

Ther Adv Ophthalmol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.
Ramin Tadayoni, Liliana P Paris, Carl J Danzig, Francis Abreu, Arshad M Khanani, András Seres

Ophthalmology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Tien Y Wong, Zdenka Haskova, Kemal Asik, Caroline R Baumal, Karl G Csaky, András I Seres

Ophthalmology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
David M Brown, David S Boyer, Diana V Do, Charles C Wykoff, Taiji Sakamoto, András Seres

Lancet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale.
Lars-Olof Hattenbach, Francis Abreu, Pablo Arrisi, Karen Basu, Carl J Danzig, András Seres

Ophthalmol Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes of Eyes with Intraocular Inflammation after Brolucizumab: Post Hoc Analysis of HAWK and HARRIER.
Michael Singer, Thomas A Albini, András Seres, Caroline R Baumal, Soumil Parikh

Ophthalmol Retina· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.
Caroline R Baumal, Bahram Bodaghi, Michael Singer, David J Tanzer, András Seres

Ophthalmol Retina· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author reply: To PMID 23021093.
Rufino Silva, Ruth Axer-Siegel, Bora Eldem, Robyn Guymer, Bernd Kirchhof, Andras Seres

Ophthalmology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degeneration.
Rufino Silva, Ruth Axer-Siegel, Bora Eldem, Robyn Guymer, Bernd Kirchhof, Andras Seres

Ophthalmology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boundary detection errors on optical coherence tomography images in patients with diabetic retinopathy.
Miklos Schneider, Andras Seres, Gabor Borgulya, Janos Nemeth

Ophthalmic Surg Lasers Imaging· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central corneal thickness measurements with optical coherence tomography and ultrasound pachymetry in healthy subjects and in patients after photorefractive keratectomy.
Miklos Schneider, Gabor Borgulya, Andras Seres, Zoltan Nagy, Janos Nemeth

Eur J Ophthalmol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Maria L Ribeiro, Andras I Seres, Angela M Carneiro, Michael Stur, Alain Zourdani

Graefes Arch Clin Exp Ophthalmol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Photodynamic therapy in age-related macular degeneration].
András Seres, András Papp, Ildikó Süveges

Orv Hetil· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photodynamic (verteporfin) therapy for retinal capillary haemangioma, with monitoring of feeder and draining blood vessel diameters.
Antal Szabó, Zsuzsanna Géhl, András Seres

Acta Ophthalmol Scand· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of macular degeneration].
András Seres

Orv Hetil· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diameters of the human retinal branch vessels do not change in darkness.
György Barcsay, András Seres, János Németh

Invest Ophthalmol Vis Sci· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation delay in patients affected with exudative age-related macular degeneration.
Walid M Haddad, Andras Seres, Gabriel Coscas, Gisèle Soubrane

Graefes Arch Clin Exp Ophthalmol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis